Portugal/ Novo Nordisk VP on Striking a Balance Between Reimboursement & Prevention
Paula Barriga, VP & GM at Novo Nordisk Portugal, discusses the high prevalence of obesity, which affects over two million people in a country where none of the available pharmacological…